As investors, we are all looking to get in on the ground floor of a fantastic stock both for returns and maybe, gloating rights to our friends. Some of the best performing stocks are in the healthcare and biotechnology sectors with industry stocks making up 7% of ASX200 companies. With many target diseases and conditions,
Read More
Despite the many advances in cancer therapy, we still haven’t quite hit the nail on the head, with cancer still responsible for 12% of all deaths worldwide each year. The advancement of cancer therapies and the growing body of research is impressive to say the least, yet cancer patients of today do not fare much
Read More
Biotech company Imagion Biosystems (ASX: IBX) has secured a major boost in resources having secured Siemens Healthineers (FWB: SHL) as a collaboration partner for their proprietary cancer detecting agent. The collaboration will centre around Imagion’s MagSense™ nanoparticles which are designed to be visible on a MRI scan once they attach to cancer cells. MagSense™ has
Read More
Australian biotech company Immutep (ASX: IMM, NASDAQ: IMMP) has delivered impressive Phase I clinical trial results for its TACTI-mel trial which has observed significant tumour size shrinkage in the majority of trial patients over the 12 month trial period. The trials tested 24 patients with melanoma which were located in areas not capable of being
Read More